These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10505723)

  • 41. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imprint cytology of gastric mucosa biopsy--fast, simple and reliable method for detection of Helicobacter pylori infection.
    Knezević Stromar I; Jakić-Razumović J; Knezević-Obad A
    Coll Antropol; 2008 Mar; 32(1):171-5. PubMed ID: 18496910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Helicobacter pylori revolution: radiologic perspective.
    Levine MS; Rubesin SE
    Radiology; 1995 Jun; 195(3):593-6. PubMed ID: 7753977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
    Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
    Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Helicobacter pylori and erosive lesions of the gastric mucosa in cirrhosis].
    Mosca S; Balzano A; Rocco VP; Di Blasi A; Piccirillo MM; Gigliotti T
    Gastroenterol Clin Biol; 1991; 15(12):983-4. PubMed ID: 1783258
    [No Abstract]   [Full Text] [Related]  

  • 46. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions.
    Zhang Z; Yuan Y; Gao H; Dong M; Wang L; Gong YH
    World J Gastroenterol; 2001 Dec; 7(6):779-82. PubMed ID: 11854900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy.
    Heresbach D; Raoul JL; Bretagne JF; Minet J; Donnio PY; Ramée MP; Siproudhis L; Gosselin M
    Gut; 1992 Dec; 33(12):1608-11. PubMed ID: 1487160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HISTOPATHOLOGICAL EVALUATION OF H. PYLORI ASSOCIATED GASTRIC LESIONS IN BENIN CITY, NIGERIA.
    Udoh MO; Obaseki DE
    East Afr Med J; 2012 Dec; 89(12):408-13. PubMed ID: 26852453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Helicobacter pylori and gastroduodenal disease in our patients: 2-year experience].
    Brigić E; Hodzić L; Zildzić M
    Med Arh; 2000; 54(5-6):313-6. PubMed ID: 11219914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic ultrasound features of protein-losing gastropathy with hypertrophic gastric folds.
    Hizawa K; Kawasaki M; Yao T; Aoyagi K; Suekane H; Kawakubo K; Fujishima M
    Endoscopy; 2000 May; 32(5):394-7. PubMed ID: 10817179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Status of oral mucosa and periodontal tissue in children with gastroduodenal diseases associated with Helicobacter pylori].
    Urazova RZ; Shamsutdinov NSh; Kazantseva TIu
    Stomatologiia (Mosk); 2001; 80(1):20-2. PubMed ID: 11236139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxic factors of Helicobacter pylori.
    Mégraud F
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S5-10. PubMed ID: 7735936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preventing stomach carcinoma. Helicobacter eradication in risk patients].
    MMW Fortschr Med; 2006 Nov; 148(45):52-3. PubMed ID: 17615751
    [No Abstract]   [Full Text] [Related]  

  • 54. [Helicobacter pylori and congestive gastropathy].
    Dai L; Wu X
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):22-3. PubMed ID: 10366979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Helicobacter pylori and gastroduodenal pathology in patient with chronic renal insufficiency undergoing dialysis].
    Calvet X; Almirall J; López T
    Nefrologia; 2002; 22(4):318-24. PubMed ID: 12369122
    [No Abstract]   [Full Text] [Related]  

  • 56. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-losing gastroenteropathy and gastric polyps: successful treatment by Helicobacter pylori eradication.
    Sato T; Chiguchi G; Inamori M; Sakai H; Fujisawa N; Akiyama T; Akimoto K; Fujita K; Takahashi H; Yoneda M; Abe Y; Kubota K; Ueno N; Nakajima A
    Digestion; 2007; 75(2-3):99. PubMed ID: 17510554
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent advances in Helicobacter pylori pathogenesis.
    Sibony M; Jones NL
    Curr Opin Gastroenterol; 2012 Jan; 28(1):30-5. PubMed ID: 22157439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
    Gail MH; Brown LM; You WC
    J Natl Cancer Inst; 2001 Apr; 93(7):559-60. PubMed ID: 11287457
    [No Abstract]   [Full Text] [Related]  

  • 60. Resolution of gastrointestinal protein loss after Helicobacter pylori eradication in a patient with hypertrophic lymphocytic gastritis.
    Madisch A; Aust D; Morgner A; Grossmann D; Schmelz R; Kropp J; Ehninger G; Baretton G; Miehlke S
    Helicobacter; 2004 Dec; 9(6):629-31. PubMed ID: 15610076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.